Report Detail

Request for Sample of this report

Pharma & Healthcare Global Meningococcal Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2996125
    • |
  • 21 February, 2019
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Scope of the Report:
Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.

The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.

The worldwide market for Meningococcal Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Meningococcal Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Quadrivalent
Bivalent
Others

Market Segment by Applications, can be divided into
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccine, with price, sales, revenue and global market share of Meningococcal Vaccine in 2017 and 2018.
Chapter 3, the Meningococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Meningococcal Vaccine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Quadrivalent
      • 1.2.2 Bivalent
      • 1.2.3 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Pneumonia
      • 1.3.2 Meningitis
      • 1.3.3 Bacteremia
      • 1.3.4 Others (Arthritis, Conjunctivitis, Urethritis)
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Novartis
      • 2.1.1 Business Overview
      • 2.1.2 Meningococcal Vaccine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 GSK
      • 2.2.1 Business Overview
      • 2.2.2 Meningococcal Vaccine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Merck
      • 2.3.1 Business Overview
      • 2.3.2 Meningococcal Vaccine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 CSL
      • 2.4.1 Business Overview
      • 2.4.2 Meningococcal Vaccine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Baxter
      • 2.5.1 Business Overview
      • 2.5.2 Meningococcal Vaccine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 JN International Medical Corporation
      • 2.6.1 Business Overview
      • 2.6.2 Meningococcal Vaccine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Serum Institute of India
      • 2.7.1 Business Overview
      • 2.7.2 Meningococcal Vaccine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bio-Med
      • 2.8.1 Business Overview
      • 2.8.2 Meningococcal Vaccine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 China National Biotec Group
      • 2.9.1 Business Overview
      • 2.9.2 Meningococcal Vaccine Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Hualan Bio
      • 2.10.1 Business Overview
      • 2.10.2 Meningococcal Vaccine Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Walvax
      • 2.11.1 Business Overview
      • 2.11.2 Meningococcal Vaccine Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Zhifei
      • 2.12.1 Business Overview
      • 2.12.2 Meningococcal Vaccine Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Meningococcal Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Meningococcal Vaccine Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Meningococcal Vaccine Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Meningococcal Vaccine Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Meningococcal Vaccine Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Meningococcal Vaccine Market Analysis by Regions

    • 4.1 Global Meningococcal Vaccine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Meningococcal Vaccine Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Meningococcal Vaccine Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 4.3 Europe Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 4.5 South America Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (2014-2019)

    5 North America Meningococcal Vaccine by Country

    • 5.1 North America Meningococcal Vaccine Sales, Revenue and Market Share by Country
      • 5.1.1 North America Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 5.3 Canada Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Meningococcal Vaccine Sales and Growth Rate (2014-2019)

    6 Europe Meningococcal Vaccine by Country

    • 6.1 Europe Meningococcal Vaccine Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 6.3 UK Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 6.4 France Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 6.5 Russia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 6.6 Italy Meningococcal Vaccine Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Meningococcal Vaccine by Country

    • 7.1 Asia-Pacific Meningococcal Vaccine Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
    • 7.2 China Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 7.3 Japan Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 7.4 Korea Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 7.5 India Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2014-2019)

    8 South America Meningococcal Vaccine by Country

    • 8.1 South America Meningococcal Vaccine Sales, Revenue and Market Share by Country
      • 8.1.1 South America Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Meningococcal Vaccine Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Meningococcal Vaccine by Countries

    • 9.1 Middle East and Africa Meningococcal Vaccine Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Meningococcal Vaccine Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Meningococcal Vaccine Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Meningococcal Vaccine Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Meningococcal Vaccine Sales and Growth Rate (2014-2019)

    10 Global Meningococcal Vaccine Market Segment by Type

    • 10.1 Global Meningococcal Vaccine Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Meningococcal Vaccine Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Meningococcal Vaccine Revenue and Market Share by Type (2014-2019)
    • 10.2 Quadrivalent Sales Growth and Price
      • 10.2.1 Global Quadrivalent Sales Growth (2014-2019)
      • 10.2.2 Global Quadrivalent Price (2014-2019)
    • 10.3 Bivalent Sales Growth and Price
      • 10.3.1 Global Bivalent Sales Growth (2014-2019)
      • 10.3.2 Global Bivalent Price (2014-2019)
    • 10.4 Others Sales Growth and Price
      • 10.4.1 Global Others Sales Growth (2014-2019)
      • 10.4.2 Global Others Price (2014-2019)

    11 Global Meningococcal Vaccine Market Segment by Application

    • 11.1 Global Meningococcal Vaccine Sales Market Share by Application (2014-2019)
    • 11.2 Pneumonia Sales Growth (2014-2019)
    • 11.3 Meningitis Sales Growth (2014-2019)
    • 11.4 Bacteremia Sales Growth (2014-2019)
    • 11.5 Others (Arthritis, Conjunctivitis, Urethritis) Sales Growth (2014-2019)

    12 Meningococcal Vaccine Market Forecast (2019-2024)

    • 12.1 Global Meningococcal Vaccine Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Meningococcal Vaccine Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Meningococcal Vaccine Market Forecast (2019-2024)
      • 12.2.2 Europe Meningococcal Vaccine Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Meningococcal Vaccine Market Forecast (2019-2024)
      • 12.2.4 South America Meningococcal Vaccine Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Meningococcal Vaccine Market Forecast (2019-2024)
    • 12.3 Meningococcal Vaccine Market Forecast by Type (2019-2024)
      • 12.3.1 Global Meningococcal Vaccine Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Meningococcal Vaccine Market Share Forecast by Type (2019-2024)
    • 12.4 Meningococcal Vaccine Market Forecast by Application (2019-2024)
      • 12.4.1 Global Meningococcal Vaccine Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Meningococcal Vaccine Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Meningococcal Vaccine . Industry analysis & Market Report on Meningococcal Vaccine is a syndicated market report, published as Global Meningococcal Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Meningococcal Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,752.68
      		4,129.02
      		5,505.36
      		3,208.56
      		4,812.84
      		6,417.12
      		540,444.00
      		810,666.00
      		1,080,888.00
      		290,580.00
      		435,870.00
      		581,160.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo